血清EB病毒基因、癌胚抗原联合铁蛋白检测在鼻咽癌诊断中的临床价值
2018-10-11赵淼陈晓鸿
赵淼 陈晓鸿
【摘要】目的:探讨在鼻咽癌(NPC)患者诊断中联合检测血清EB病毒基因(EBV-DNA)、癌胚抗原(CEA)、铁蛋白(SF)的临床价值。方法:将2017年1月-2018年3月本院收治的NPC患者80例作为NPC组,另选同期收治的80例良性鼻炎患者作为良性鼻炎组,再抽取80例健康体检者作为对照组,对三组的EBV-DNA、CEA以及SF进行检测。结果:NPC组的EBV-DNA、CEA、SF的水平均显著高于良性鼻炎组与对照组,差异均有统计学意义(P<0.05);良性鼻炎组的EBV-DNA、CEA、SF的水平均高于对照组,差异均有统计学意义(P<0.05)。单纯检测EBV-DNA、CEA、SF的特异度分别为88.89%(64/72)、87.34%(69/79)、81.01%(64/79),单纯检测EBV-DNA、CEA、SF的特异度对比,差异无统计学意义(P>0.05);但单纯检测EBV-DNA的敏感度高于单纯检测CEA、SF(P>0.05)。结论:对NPC采取血清EB病毒基因、CEA、SF联合检测的敏感度高,值得推广。
【关键词】鼻咽癌;EBV-DNA;CEA;SF
Clinical Value of Serum EB Virus Gene,Carcinoembryonic Antigen and Ferritin in Diagnosis of Nasopharyngeal Carcinoma/ZHAO Miao,CHEN Xiaohong.//Medical Innovation of China,2018,15(23):-137
【Abstract】Objective:To explore the clinical value of serum EB virus gene(EBV-DNA),cancer embryo antigen(CEA) and ferritin(SF) in patients with nasopharyngeal carcinoma(NPC).Method:From January 2017 to March 2018,80 patients with NPC were treated in our hospital as NPC group,another 80 cases of benign rhinitis treated in the same period were selected as benign rhinitis group,another 80 healthy people were selected as control group,the EBV-DNA,CEA and SF of the three groups were detected.Result:The EBV-DNA,CEA and SF levels of the benign rhinitis group and the control group compared with the NPC group,the differences were statistically significant(P<0.05).The levels of EBV-DNA,CEA and SF in the benign rhinitis group were all higher than those in the control group,the differences were statistically significant(P<0.05).The specificity of EBV-DNA,CEA and SF were respectively 88.89%(64/72),87.34%(69/79),81.01%(64/79).The specificity comparison of EBV-DNA,CEA and SF was simply detected,the difference was not statistically significant(P>0.05).However,the sensitivity of EBV-DNA detection was higher than that of CEA and SF(P>0.05).Conclusion:The sensitivity of serum EB virus gene,CEA and SF in NPC is high and worth promoting.
【Key words】Nasopharyngeal carcinoma;EBV-DNA;CEA;SF
First-authors address:The District Otolaryngology Hospital of Shenzhen Longgang ,Shenzhen 518172,China
doi:10.3969/j.issn.1674-4985.2018.23.035
在耳鼻喉科臨床中,鼻咽癌属于常见的一种恶性肿瘤疾病,是危害人类身体健康的重要疾病之一,其发病率在头颈部肿瘤疾病中居于首位[1-2]。另外,NPC的转移性与侵袭性均比较强,目前在世界各地均呈现出广泛流行趋势,而在中国主要发生在福建、广东等地[3-4]。为了分析血清EB病毒基因、CEA以及SF联合检测对NPC的诊断价值,本次研究抽取了240例对象进行分析,现将具体情况报道如下。
1资料与方法
1.1一般资料将2017年1月-2018年3月本院收治的NPC患者80例作为NPC组,另选同期收治的80例良性鼻炎患者作为良性鼻炎组,再抽取80例健康体检者作为对照组。纳入标准:病理检查确诊为鼻咽癌;男女不限;年龄50~70岁;通过本院伦理学会审核,自愿参与研究,而且具有较高的依从性,积极配合治疗[5]。排除标准:语言障碍者、精神障碍者;合并肾、肝等严重脏器疾病者;药物过敏者;曾进行化疗或者放疗治疗;存在放化疗禁忌证;妊娠及哺乳者。
1.2检测方法三组受检者均在清除空腹状态下采集3~4 mL的静脉血,按照3 000 r/min的标准开展10 min的离心处理后,将上层血清收集并分别装在三个无菌EP管内,保存在-20 ℃的冰柜中待检。其……
